NDC Package 0002-2344-00 Olanzapine Pamoate

Injection, Powder, For Suspension, Extended Release - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0002-2344-00
Package Description:
2.7 mL in 1 VIAL
Product Code:
Non-Proprietary Name:
Olanzapine Pamoate
Substance Name:
Olanzapine Pamoate
Usage Information:
Olanzapine injection is used to treat a certain mental/mood disorder (schizophrenia). Olanzapine helps you to think more clearly, feel less nervous, and take part in everyday life. It may also help to decrease hallucinations (hearing/seeing things that are not there). Extended-release olanzapine injection is a long-acting psychiatric medication called an atypical antipsychotic. It works by helping to restore the balance of certain natural substances in the brain. Talk to the doctor about the risks and benefits of treatment (especially when used in teenagers). See also Warning/Precautions sections.
11-Digit NDC Billing Format:
00002234400
Product Type:
Drug For Further Processing
Labeler Name:
Eli Lilly And Company
Dosage Form:
Injection, Powder, For Suspension, Extended Release - A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).
Active Ingredient(s):
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
12-11-2009
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0002-2344-00?

The NDC Packaged Code 0002-2344-00 is assigned to an UNFINISHED drug package of 2.7 ml in 1 vial of Olanzapine Pamoate, drug for further processing labeled by Eli Lilly And Company. The product's dosage form is injection, powder, for suspension, extended release and is administered via form.

Is NDC 0002-2344 included in the NDC Directory?

Yes, Olanzapine Pamoate is an UNFINISHED PRODUCT with code 0002-2344 that is active and included in the NDC Directory. The product was first marketed by Eli Lilly And Company on December 11, 2009 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 0002-2344-00?

The 11-digit format is 00002234400. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20002-2344-005-4-200002-2344-00